Literature DB >> 12782874

Operative treatment of flatfoot with talocalcaneal coalition.

Sandro Giannini1, Francesco Ceccarelli, Francesca Vannini, Elena Baldi.   

Abstract

Rigid flatfoot or peroneal spastic flatfoot often is associated with a congenital fibrous, cartilaginous, or osseous union of two tarsal bones or more, potentially causing great difficulties in its treatment. Since 1996, 12 patients (14 feet) with painful flatfoot and restricted motion of the hindfoot attributable to talocalcaneal coalition, were treated by resection of the coalition and subtalar arthroereisis by a bioreabsorbable implant. The results were evaluated by the ankle hindfoot clinical rating system of the American Orthopaedic Foot and Ankle Society. These clinical results also were evaluated statistically. Radiographs and computed tomography scans were taken preoperatively and postoperatively. Eight (57.1% of patients) had excellent results, three (21.4% of patients) had good results, and three (21.4% of patients) had fair results. No poor results, or subjective or objective complications were reported. On the basis of these early results, arthroereisis by implanting a bioreabsorbable device after removal of the tarsal coalition, seems to be an effective procedure for the treatment of symptomatic flatfoot associated with talocalcaneal coalitions: correcting the relationship between talus and calcaneus, restoring the alignment of the hindfoot, and reducing pain.

Entities:  

Mesh:

Year:  2003        PMID: 12782874     DOI: 10.1097/01.blo.0000069897.31220.7a

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  9 in total

Review 1.  Bioabsorbable implants for subtalar arthroereisis in pediatric flatfoot.

Authors:  C Faldini; A Mazzotti; A Panciera; F Perna; N Stefanini; S Giannini
Journal:  Musculoskelet Surg       Date:  2017-07-17

2.  Coalition resection and medial displacement calcaneal osteotomy for treatment of symptomatic talocalcaneal coalition: functional and clinical outcome.

Authors:  Ossama El Shazly; Mohammed Mokhtar; Nasef Abdelatif; Mohamed Hegazy; Rana El Hilaly; Abeer El Zohairy; Eman Tawfik
Journal:  Int Orthop       Date:  2014-09-25       Impact factor: 3.075

3.  Therapeutic Outcomes of Kalix II in Treating Juvenile Flexible Flatfoot.

Authors:  Le Cao; Xu-Dong Miao; Yong-Ping Wu; Xiang-Feng Zhang; Qiang Zhang
Journal:  Orthop Surg       Date:  2017-02       Impact factor: 2.071

Review 4.  [Diagnosis and treatment of tarsal coalitions and synostoses in children and adolescents].

Authors:  J Hamel
Journal:  Orthopade       Date:  2013-06       Impact factor: 1.087

5.  [Evans lateral lengthening calcaneal osteotomy in treatment of talocalcaneal coalition with hindfoot valgus deformity].

Authors:  Lin Shang; Xiangyu Wang; Aiguo Wang; Guanghui Jia; Qi Li; Xiaolong Zhang; Fuqiang Ma; Yalei Wang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-02-15

6.  Talocalcaneal coalition: A focus on radiographic findings and sites of bridging.

Authors:  Soon Hyuck Lee; Hyung Jun Park; Eui Dong Yeo; Young Koo Lee
Journal:  Indian J Orthop       Date:  2016 Nov-Dec       Impact factor: 1.251

7.  Tarsal coalition resections: a long-term retrospective analysis of 97 resections in 78 patients.

Authors:  Amol Saxena; Ryan Allen; Anthony Wright; Filippo Migliorini; Nicola Maffulli
Journal:  J Orthop Surg Res       Date:  2022-10-17       Impact factor: 2.677

Review 8.  Talocalcaneal coalition combined with flatfoot in children: diagnosis and treatment: a review.

Authors:  Binghua Zhou; Kanglai Tang; Mark Hardy
Journal:  J Orthop Surg Res       Date:  2014-12-14       Impact factor: 2.359

9.  Operative versus nonoperative treatment in children with painful rigid flatfoot and talocalcaneal coalition.

Authors:  Giovanni Luigi Di Gennaro; Stefano Stallone; Eleonora Olivotto; Paola Zarantonello; Marina Magnani; Tullia Tavernini; Stefano Stilli; Giovanni Trisolino
Journal:  BMC Musculoskelet Disord       Date:  2020-03-24       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.